Last 12 months
Inside the activity.
0 purchase rows · 22 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 19, 2017 Filed Jan 24, 2017 02:04 UTC |
Hardy Ralph EEVP, Gen. Counsel & Secretary
|
GrantCommon Stock | 36,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001600781-17-000036 · edgar.xml · nonDerivative · entry 1 Hardy Ralph E · CIK 0001388841 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,205 F1 · shares: Represents shares of restricted stock that will vest as follows: 14,675 shares will vest in three equal annual installments beginning on January 19, 2018, 16,509 shares will vest upon achievement of specified performance targets at the end of a three-year measuring period ending on December 26, 2019, and 5,503 shares will vest upon achievement of specified performance targets at the end of a one-year measuring period ending on December 26, 2019. Read SEC document |
| January 19, 2017 Filed Jan 24, 2017 02:01 UTC |
Scherping Katherine LeeChief Financial Officer
|
GrantCommon Stock | 48,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001600781-17-000035 · edgar.xml · nonDerivative · entry 1 Scherping Katherine Lee · CIK 0001330786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,698 F1 · shares: Represents shares of restricted stock that will vest as follows: 19,297 shares will vest in three equal annual installments beginning on January 19, 2018, 21,709 shares will vest upon achievement of specified performance targets at the end of a three-year measuring period ending on December 26, 2019, and 7,237 shares will vest upon achievement of specified performance targets at the end of a one-year measuring period ending on December 26, 2019. Read SEC document |
| January 19, 2017 Filed Jan 24, 2017 01:55 UTC |
Marks Clifford EPresident
|
GrantCommon Stock | 159,487 | $0.00 | $0.00 |
DisclosureSEC source: 0001600781-17-000032 · edgar.xml · nonDerivative · entry 1 Marks Clifford E · CIK 0001388840 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510,704 F1 · shares: Represents shares of restricted stock that will vest as follows: 63,795 shares will vest in three equal annual installments beginning on January 19, 2018, 71,769 shares will vest upon achievement of specified performance targets at the end of a three-year measuring period ending on December 26, 2019, and 23,923 shares will vest upon achievement of specified performance targets at the end of a one-year measuring period ending on December 26, 2019. Read SEC document |
| January 19, 2017 Filed Jan 24, 2017 01:52 UTC |
Lesinski Thomas F.Director
|
GrantRestricted Stock Units · Derivative | 7,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001600781-17-000030 · edgar.xml · derivative · entry 1 Lesinski Thomas F. · CIK 0001629303 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,432 Underlying: Common Stock · 7,432 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit respresents the right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The Restricted Stock Units are scheduled to vest on February 19, 2018, provided the reporting person continues to be a director of the Issuer on that date, except that if he dies prior to the vesting date the Restricted Stock Units will vest in full on the date of death. The Restricted Stock Units will convert to shares of the Issuer's common stock and the shares will be delivered to the reporting person as soon as practicable following the vesting date, unless the reporting person has elected to defer receipt of the shares for a period not to exceed five years. F2 · derivative.expiration_date: The Restricted Stock Units are scheduled to vest on February 19, 2018, provided the reporting person continues to be a director of the Issuer on that date, except that if he dies prior to the vesting date the Restricted Stock Units will vest in full on the date of death. The Restricted Stock Units will convert to shares of the Issuer's common stock and the shares will be delivered to the reporting person as soon as practicable following the vesting date, unless the reporting person has elected to defer receipt of the shares for a period not to exceed five years. Read SEC document |
| January 19, 2017 Filed Jan 24, 2017 01:46 UTC |
Lanning Stephen LDirector
|
GrantRestricted Stock Units · Derivative | 7,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001600781-17-000028 · edgar.xml · derivative · entry 1 Lanning Stephen L · CIK 0001388843 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,432 Underlying: Common Stock · 7,432 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The Restricted Stock Units are scheduled to vest on February 19, 2018, provided the reporting person continues to be a director of the Issuer on that date, except that if he dies prior to the vesting date the Restricted Stock Units will vest in full on the date of death. The Restricted Stock Units will convert to shares of the Issuer's common stock and the shares will be delivered to the reporting person as soon as practicable following the vesting date, unless the reporting person has elected to defer receipt of the shares for a period not to exceed five years. F2 · derivative.expiration_date: The Restricted Stock Units are scheduled to vest on February 19, 2018, provided the reporting person continues to be a director of the Issuer on that date, except that if he dies prior to the vesting date the Restricted Stock Units will vest in full on the date of death. The Restricted Stock Units will convert to shares of the Issuer's common stock and the shares will be delivered to the reporting person as soon as practicable following the vesting date, unless the reporting person has elected to defer receipt of the shares for a period not to exceed five years. Read SEC document |
| January 19, 2017 Filed Jan 24, 2017 01:42 UTC |
Madison Paula WilliamsDirector
|
GrantRestricted Stock Units · Derivative | 7,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001600781-17-000026 · edgar.xml · derivative · entry 1 Madison Paula Williams · CIK 0001601579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,432 Underlying: Common Stock · 7,432 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The Restricted Stock Units are scheduled to vest on February 19, 2018, provided the reporting person continues to be a director of the Issuer on that date, except that if she dies prior to the vesting date the Restricted Stock Units will vest in full on the date of death. The Restricted Stock Units will convert to shares of the Issuer's common stock and the shares will be delivered to the reporting person as soon as practicable following the vesting date, unless the reporting person has elected to defer receipt of the shares for a period not to exceed five years. F2 · derivative.expiration_date: The Restricted Stock Units are scheduled to vest on February 19, 2018, provided the reporting person continues to be a director of the Issuer on that date, except that if she dies prior to the vesting date the Restricted Stock Units will vest in full on the date of death. The Restricted Stock Units will convert to shares of the Issuer's common stock and the shares will be delivered to the reporting person as soon as practicable following the vesting date, unless the reporting person has elected to defer receipt of the shares for a period not to exceed five years. Read SEC document |
| January 19, 2017 Filed Jan 24, 2017 01:40 UTC |
HAAS DAVID RDirector
|
GrantRestricted Stock Units · Derivative | 7,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001600781-17-000024 · edgar.xml · derivative · entry 1 HAAS DAVID R · CIK 0001282689 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,432 Underlying: Common Stock · 7,432 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The Restricted Stock Units are scheduled to vest on February 19, 2018, provided the reporting person continues to be a director of the Issuer on that date, except that if he dies prior to the vesting date the Restricted Stock Units will vest in full on the date of death. The Restricted Stock Units will convert to shares of the Issuer's common stock and the shares will be delivered to the reporting person as soon as practicable following the vesting date, unless the reporting person has elected to defer receipt of the shares for a period not to exceed five years. F2 · derivative.expiration_date: The Restricted Stock Units are scheduled to vest on February 19, 2018, provided the reporting person continues to be a director of the Issuer on that date, except that if he dies prior to the vesting date the Restricted Stock Units will vest in full on the date of death. The Restricted Stock Units will convert to shares of the Issuer's common stock and the shares will be delivered to the reporting person as soon as practicable following the vesting date, unless the reporting person has elected to defer receipt of the shares for a period not to exceed five years. Read SEC document |
| January 19, 2017 Filed Jan 24, 2017 01:37 UTC |
Goodman Lawrence ADirector
|
GrantRestricted Stock Units · Derivative | 7,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001600781-17-000022 · edgar.xml · derivative · entry 1 Goodman Lawrence A · CIK 0001388844 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,432 Underlying: Common Stock · 7,432 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The Restricted Stock Units are scheduled to vest on February 19, 2018, provided the reporting person continues to be a director of the Issuer on that date, except that if he dies prior to the vesting date the Restricted Stock Units will vest in full on the date of death. The Restricted Stock Units will convert to shares of the Issuer's common stock and the shares will be delivered to the reporting person as soon as practicable following the vesting date, unless the reporting person has elected to defer receipt of the shares for a period not to exceed five years. F2 · derivative.expiration_date: The Restricted Stock Units are scheduled to vest on February 19, 2018, provided the reporting person continues to be a director of the Issuer on that date, except that if he dies prior to the vesting date the Restricted Stock Units will vest in full on the date of death. The Restricted Stock Units will convert to shares of the Issuer's common stock and the shares will be delivered to the reporting person as soon as practicable following the vesting date, unless the reporting person has elected to defer receipt of the shares for a period not to exceed five years. Read SEC document |
| January 19, 2017 Filed Jan 24, 2017 18:42 UTC |
England Andrew J.Director · CEO
|
GrantCommon Stock | 101,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001600781-17-000038 · edgar.xml · nonDerivative · entry 1 England Andrew J. · CIK 0001663150 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,351 F1 · shares: Represents shares of restricted stock that will vest as follows: 25,338 shares will vest in three equal annual installments beginning on January 19, 2018, 57,010 shares will vest upon achievement of specified performance targets at the end of a three-year measuring period ending on December 26, 2019, and 19,003 shares will vest upon achievement of specified performance targets at the end of a one-year measuring period ending on December 26, 2019. Read SEC document |
| January 19, 2017 Filed Jan 31, 2017 01:51 UTC |
House Geri REVP, People & Organization
|
GrantCommon Stock | 33,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001600781-17-000043 · edgar.xml · nonDerivative · entry 1 House Geri R · CIK 0001696095 · EVP, People & Organization 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,472 F1 · shares: Represents shares of restricted stock that will vest as follows: 13,501 shares will vest in three equal annual installments beginning on January 19, 2018, 15,188 shares will vest upon achievement of specified performance targets at the end of a three-year measuring period ending on December 26, 2019, and 5,062 shares will vest upon achievement of specified performance targets at the end of a one-year measuring period ending on December 26, 2019. Read SEC document |
| January 15, 2017 Filed Jan 18, 2017 17:53 UTC |
Marks Clifford EPresident
|
Tax withholdingCommon Stock | 5,064 | $15.00 | $75,960.00 |
DisclosureSEC source: 0001600781-17-000018 · edgar.xml · nonDerivative · entry 1 Marks Clifford E · CIK 0001388840 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,217 F1 · shares: Represents withholding of shares to satisfy tax obligations upon the vesting of restricted stock. Read SEC document |
| January 15, 2017 Filed Jan 18, 2017 17:51 UTC |
Hardy Ralph EEVP, Gen. Counsel & Secretary
|
Tax withholdingCommon Stock | 1,309 | $15.00 | $19,635.00 |
DisclosureSEC source: 0001600781-17-000016 · edgar.xml · nonDerivative · entry 1 Hardy Ralph E · CIK 0001388841 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,518 F1 · shares: Represents withholding of shares to satisfy tax obligations upon the vesting of restricted stock. Read SEC document |
| January 01, 2017 Filed Jan 4, 2017 23:44 UTC |
England Andrew J.Director · CEO
|
Tax withholdingCommon Stock | 5,542 | $14.73 | $81,633.66 |
DisclosureSEC source: 0001600781-17-000002 · edgar.xml · nonDerivative · entry 1 England Andrew J. · CIK 0001663150 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,000 F1 · shares: Represents withholding of shares to satisfy tax obligations upon the vesting of restricted stock. Read SEC document |
| November 25, 2016 Filed Nov 29, 2016 21:39 UTC |
Rosabal Alfonso P JrEVP, COO & Chief Tech. Officer
|
SaleCommon Stock | 2,615 | $16.01 | $41,873.47 |
DisclosureSEC source: 0001600781-16-000225 · edgar.xml · nonDerivative · entry 1 Rosabal Alfonso P Jr · CIK 0001595900 · EVP, COO & Chief Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,697 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2016. F2 · price: This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.